Literature DB >> 9541583

Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses.

Y J Kim1, S H Kim, P Mantel, B S Kwon.   

Abstract

Our present study provides evidence that the 4-1BB signal is critical to CD28 co-stimulation in maintaining T cell activation when CD28 has been down-regulated because of repeated stimulation. The 4-1BB signal synergized with CD28 co-stimulation by lowering the threshold of anti-CD28 required to sustain proliferation and IL-2 production. The 4-1BB signal also modulated CD28-mediated cytokine profiles by markedly enhancing Th1 but suppressing Th2-type cytokine production. The 4-1BB signal generated Th1-type cells, as identified by intracellular IFN-gamma production. IFN-gamma induction was detected preferentially in 4-1BB-expressing cells, but not in those expressing CD30. 4-1BB and CD30 were induced in both CD4+ and CD8+ cells, but the location of the two molecules was mutually exclusive in each T cell subset. Our study suggests that the 4-1BB signal regulates CD28 co-stimulation in the targeted subset cells to favor Th1 development and maintain long-term cell growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541583     DOI: 10.1002/(SICI)1521-4141(199803)28:03<881::AID-IMMU881>3.0.CO;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis.

Authors:  P Maerten; B S Kwon; C Shen; G De Hertogh; P Cadot; D M A Bullens; L Overbergh; C Mathieu; G Van Assche; K Geboes; P Rutgeerts; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 2.  Therapeutic vaccination with tumor cells that engage CD137.

Authors:  Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  J Mol Med (Berl)       Date:  2003-02-08       Impact factor: 4.599

3.  IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.

Authors:  Young H Kim; Beom K Choi; Woo J Kang; Kwang H Kim; Sang W Kang; Andrew L Mellor; David H Munn; Byoung S Kwon
Journal:  J Leukoc Biol       Date:  2009-02-13       Impact factor: 4.962

4.  4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease.

Authors:  Douglas G Mack; Allison K Lanham; Brent E Palmer; Lisa A Maier; Tania H Watts; Andrew P Fontenot
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

5.  Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammation.

Authors:  Min Dai; Huafeng Wei; Yuen Yee Yip; Qinghua Feng; Kecheng He; Viorica Popov; Ingegerd Hellstrom; Karl Erik Hellstrom
Journal:  J Immunother       Date:  2013-05       Impact factor: 4.456

6.  Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.

Authors:  Yun-Le Wan; Shu-Sen Zheng; Zhi-Cheng Zhao; Min-Wei Li; Chang-Ku Jia; Hao Zhang
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

7.  CD137-mediated immunotherapy for allergic asthma.

Authors:  Tobias Polte; Juergen Foell; Christoph Werner; Heinz-Gerd Hoymann; Armin Braun; Stefan Burdach; Robert S Mittler; Gesine Hansen
Journal:  J Clin Invest       Date:  2006-03-09       Impact factor: 14.808

8.  The nature of activatory and tolerogenic dendritic cell-derived signal II.

Authors:  Ghaith Bakdash; Simone P Sittig; Tjeerd van Dijk; Carl G Figdor; I Jolanda M de Vries
Journal:  Front Immunol       Date:  2013-02-28       Impact factor: 7.561

9.  Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for gliblastoma.

Authors:  Xiangli Cui; Zhiqin Xu; Zhigang Zhao; Dali Sui; Xiaohui Ren; Qiming Huang; Jiazhen Qin; Limin Hao; Zhenguang Wang; Li Shen; Song Lin
Journal:  Int J Biol Sci       Date:  2013-01-16       Impact factor: 6.580

Review 10.  Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors.

Authors:  Daniele E Mascarelli; Rhubia S M Rosa; Jessica M Toscaro; Isadora F Semionatto; Luciana P Ruas; Carolinne T Fogagnolo; Gabriel C Lima; Marcio C Bajgelman
Journal:  Front Cell Dev Biol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.